Group 1 - The Ministry of Human Resources and Social Security and the Ministry of Finance announced an increase in basic pension levels for retirees starting January 1, 2025, with an overall adjustment level of 2% based on the average monthly basic pension of retirees in 2024 [2] - The Chinese government is taking measures to combat the smuggling of strategic minerals such as antimony and gallium, with a special action launched in May to prevent illegal outflows [2] - A new agreement between the Chinese and Malaysian governments will allow visa-free travel for holders of ordinary passports for stays of up to 30 days, effective July 17, 2025 [3] Group 2 - The China Automobile Industry Association reported that the automotive industry saw significant growth in the first half of the year, with production and sales exceeding 15 million units, and new energy vehicle sales reaching 6.968 million units, a year-on-year increase of 41.4% [4] - The Beijing Municipal Government aims for an average annual growth of around 5% in total market consumption by 2030, with plans to create 2-3 consumption landmarks worth over 100 billion [4] - U.S. stock indices saw collective gains, with the S&P 500 and Nasdaq reaching new highs, indicating a positive market sentiment [4] Group 3 - Companies such as Tianbao Infrastructure reported a significant net profit increase of 1581.8% to 2329.27% year-on-year for the first half of the year [6] - East Sunshine projected a net profit increase of 157.48% to 192.81% for the first half of the year [7] - Southwest Securities noted that the profitability of thermal power companies is improving due to declining fuel costs, with a recovery of 11% in stock prices since late January [8] Group 4 - Zhongyuan Securities highlighted that the ongoing anti-involution policies in the chemical industry may lead to a better industry structure, recommending attention to the pesticide, organic silicon, and polyester filament sectors [9]

智通财经7月10日晚间新闻精选 3、今日有消息称智元机器人上市目的地为港股，并在推进港股IPO事宜。对此，智元机器人回应，不 属实。 4、据SMM，为避免光伏玻璃企业之间竞争加剧使得市场恶性循环，多数玻璃企业计划7月开始减产改 善供应端，行业倡议减产规模达到30%。预计在现阶段短期更多依靠市场化手段实现供给收缩，老旧产 能在上一轮下行周期中基本出清(去年下半年)。 5、广期所公告，自2025年7月14日结算时起，多晶硅期货合约涨跌停板幅度调整为9%，投机交易保证 金标准调整为11%，套期保值交易保证金标准调整为10%。 6、赛力斯：上半年净利润同比预增66%-97%。药明康德：预计上半年实现经调整归母净利润约63.15亿 元 同比增长约44%。6连板森林包装：公司原纸产品为工业包装用纸 不涉及食品用纸领域。6连板华光 环能：未发现存在对公司股票交易价格可能产生重大影响的媒体报道及市场传闻。8天5板塞力医疗：旗 下联营企业治疗性降压疫苗项目试验能否成功还存在重大不确定性。 1、美商务部长称可能于8月初与中方谈判代表会面，商务部回应：目前，双方在多个层级就经贸领域各 自关切保持密切沟通。 2、人力资源社会保障部、 ...

重要的消息有哪些 1．日前，人力资源社会保障部、财政部印发《关于2025年调整退休人员基本养老金的通知》。《通 知》明确，从2025年1月1日起，为2024年底前已按规定办理退休手续并按月领取基本养老金的退休人员 提高基本养老金水平，总体调整水平为2024年退休人员月人均基本养老金的2%。此次调整是综合考虑 物价变动和职工工资增长等各方面因素，合理确定养老金调整比例。《通知》要求，各省、自治区、直 辖市要结合本地区实际，制定具体实施方案，抓紧组织实施，尽快把调整增加的基本养老金发放到退休 人员手中。 2．在今天下午召开的商务部例行新闻发布会上，新闻发言人就中国政府是否已采取相关措施打击关键 矿产转运和走私行为作出了回应。商务部新闻发言人何咏前：锑和镓等战略矿产具有明显的军民两用管 制，对其实施出口管制，符合国际通行做法。为坚决防止非法外流，今年5月，中国国家出口管制工作 协调机制办公室，已部署开展打击战略矿产走私出口专项行动，相关信息可在商务部网站查询。同时， 中国作为负责任大国，也充分考虑各国对上述战略矿产合理民用需求，依法依规对相关出口许可申请进 行审查，并批准合规申请。 3．《中华人民共和国政府和马来西 ...

2025.07. 10 7月10日晚间，沪深两市多家上市公司发布公告，以下是第一财经对一些重要公告的汇总，供投资者 参考。 【品大事】 塞力医疗：旗下联营企业治疗性降压疫苗项目试验能否成功还存在重大不确定性 塞力医疗(603716)发布股票交易异常波动公告，公司股票连续3个交易日内日收盘价格涨幅偏离值累 计超过20%，属于股票交易异常波动的情形。公司关注到近期市场对创新药业务关注度较高。公司 旗下联营企业华纪元生物是公司于2020年1月投资的参股公司，持有其15.61%的股份，投资金额 1066.6万元，华纪元生物2024年营业收入2.68万元，净利润-238.23万元。其治疗性降压疫苗项目 HJY-ATRQβ-001已完成概念验证（POC）阶段研究和临床前研究，已于2025年6月6日获得国家药 监局（NMPA）的新药临床试验申请（IND）受理，后续还需经一期、二期临床试验，试验能否成功 还存在重大不确定性。上述投资目前对公司主营业务的影响较小，敬请投资者注意相关风险，理性决 策，审慎投资。 人福医药：股东招商生科取得增持股份专项贷款承诺函 人福医药(600079)公告，公司近日收到股东招商生命科技（武汉）有 ...

Core Viewpoint - Multiple listed companies in the Shanghai and Shenzhen markets have released important announcements, highlighting significant developments and performance forecasts that may impact investor decisions [1]. Company Announcements - **Saili Medical**: The therapeutic hypertension vaccine project by its affiliate, Huajiyuan Biotechnology, faces significant uncertainty despite recent market interest in innovative drugs. The company holds a 15.61% stake in Huajiyuan, which reported a revenue of 26,800 yuan and a net loss of 2,382,300 yuan for 2024 [3]. - **Renfu Pharmaceutical**: Shareholder,招商生科, has secured a loan commitment of up to 750 million yuan from招商银行武汉分行 to increase its stake in Renfu Pharmaceutical. The planned share buyback will occur within six months starting from July 3, 2025, with a maximum purchase price of 25.53 yuan per share [4]. - **China Merchants Energy Shipping**: The company has received a new multi-purpose heavy-lift vessel, "Mingshi," as part of its order for four eco-friendly vessels. The fleet now includes 102 operational bulk carriers, with 16 vessels on order for future delivery [5]. - **Shangwei New Materials**: The company announced a significant stock price fluctuation, with a 30% increase over two days. A share transfer agreement was signed, potentially changing the controlling shareholder to Zhiyuan Hengyue, pending shareholder approval [6]. - **Northern Rare Earth**: The trading price for rare earth concentrates has been adjusted to 19,109 yuan per ton for Q3 2025, based on market conditions [7]. - **Baotou Steel**: Similar to Northern Rare Earth, Baotou Steel has proposed an adjustment of the rare earth concentrate trading price to 19,109 yuan per ton for Q3 2025 [9]. - **Shanghai Mechanical & Electrical**: The company received approval from the Shanghai State-owned Assets Supervision and Administration Commission for the transfer of 51.137 million shares from its controlling shareholder, Shanghai Electric, without changing control [10]. Performance Forecasts - **Eyer Communication**: The company expects a net profit of approximately 463 million yuan for the first half of 2025, a year-on-year increase of about 121.13%, driven by growth in the IoT sector [12]. - **Tianbao Infrastructure**: The company forecasts a net profit of 90 million to 130 million yuan for the first half of 2025, representing a year-on-year increase of 1581.8% to 2329.27% due to tax recoveries [13]. - **China Shipbuilding**: The expected net profit for the first half of 2025 is between 2.8 billion and 3.1 billion yuan, reflecting a year-on-year increase of 98.25% to 119.49% due to improved production efficiency and order structure [14]. - **Shanghai Xiba**: The company anticipates a net profit of 99 million to 118 million yuan for the first half of 2025, a year-on-year increase of 136.47% to 181.85%, primarily due to non-recurring income [15]. - **Longyuan Technology**: The expected net profit for the first half of 2025 is between 26 million and 31 million yuan, reflecting a year-on-year increase of 116.61% to 158.26% [16]. - **Zhengbang Technology**: The company forecasts a net profit of 190 million to 210 million yuan for the first half of 2025, marking a return to profitability driven by increased pig sales [17][18]. - **Bolong Technology**: The expected net profit for the first half of 2025 is between 22 million and 28 million yuan, a year-on-year increase of 123.09% to 183.93% due to successful project deliveries [19]. - **Haitou Shares**: The company anticipates a net profit of approximately 380 million yuan for the first half of 2025, a year-on-year increase of about 233.10% due to favorable market conditions [20]. - **Chuangjiang New Materials**: The expected net profit for the first half of 2025 is between 24 million and 29 million yuan, reflecting a year-on-year increase of 42.35% to 72% [21]. - **Hudian Shares**: The company forecasts a net profit of between 1.65 billion and 1.75 billion yuan for the first half of 2025, a year-on-year increase of 44.63% to 53.4% [22]. - **Taiping Bird**: The company expects a net profit of around 77.7 million yuan for the first half of 2025, a decrease of approximately 55% due to declining retail performance [23]. - **China Satellite**: The company anticipates a loss of between 21.2 million and 41.2 million yuan for the first half of 2025, attributed to reduced contract fulfillment and increased operational costs [24]. - **ST Yatai**: The company expects a loss of between 12.6 million and 20.9 million yuan for the first half of 2025, primarily due to cash flow issues and increased non-recurring expenses [25]. Major Contracts - **Bai Da Group**: The company signed a significant leasing contract for the Hangzhou Department Store, with a rental agreement of 375 million yuan per quarter, increasing by 4.5% every three years [26]. Shareholding Changes - **Baoshui Technology**: A major shareholder plans to reduce their stake by up to 1% through market transactions between August 4 and November 3, 2025 [28].

8天5板塞力医疗：旗下联营企业治疗性降压疫苗项目试验能否成功还存在重大不确定性 智通财经7月10日电，塞力医疗(603716.SH)公告称，公司股票连续3个交易日内日收盘价格涨幅偏离值 累计超过20%，属于股票交易异常波动情形。公司关注到近期市场对创新药业务关注度较高。公司旗下 联营企业武汉华纪元生物技术开发有限公司（简称"华纪元生物"）是公司于2020年1月投资的参股公 司，持有其15.61%的股份，投资金额1,066.6万元，华纪元生物2024年营业收入2.68万元，净利润-238.23 万元。其治疗性降压疫苗项目HJY-ATRQ β-001已完成概念验证（POC）阶段研究和临床前研究，已于 2025年6月6日获得国家药监局（NMPA）的新药临床试验申请（IND）受理，后续还需经一期、二期临 床试验，试验能否成功还存在重大不确定性。上述投资目前对公司主营业务的影响较小，敬请投资者注 意相关风险，理性决策，审慎投资。 ...

Group 1 - The Civil Aviation Administration of China has established a leadership group for general aviation and low-altitude economy development, focusing on key work arrangements and cross-departmental coordination [1] - The State Council Tariff Commission has decided to impose anti-dumping duties on imported brandy from the EU starting July 5, 2025, for a period of five years [5] - The Ministry of Housing and Urban-Rural Development has conducted research in Guangdong and Zhejiang provinces, emphasizing the need to stabilize expectations, activate demand, optimize supply, and mitigate risks in the real estate market [6] Group 2 - The National Energy Administration reported that the national maximum electricity load reached 1.465 billion kilowatts on July 4, an increase of approximately 200 million kilowatts from the end of June and nearly 150 million kilowatts year-on-year, setting a historical high [8] - The China Academy of Information and Communications Technology announced that domestic smartphone shipments in May 2025 totaled 23.716 million units, a year-on-year decline of 21.8%, with 5G smartphones accounting for 89.3% of the total [9] - A total of 57 A-share listed companies have released performance forecasts for the first half of 2025, with 13 companies expecting a net profit increase of over 100% year-on-year [10] Group 3 - Sanan Optoelectronics announced that its 400G optical chip products have achieved mass shipments, while 800G optical chip products have achieved small batch shipments [11] - The Shanghai Stock Exchange's merger and acquisition review committee has approved China Shipbuilding's share swap merger with China Shipbuilding Industry Corporation, making it the largest publicly listed shipbuilding company globally with over 18% of the global market order backlog [15]

今日关注 1、商务部7月4日决定，7月5日起对原产于欧盟的进口相关白兰地征收反倾销税，实施期限5年。 2、央行发布《人民币跨境支付系统业务规则（征求意见稿）》。明确了CIPS参与者的账户管理、注 资、资金结算等详细流程。仅对参与者业务行为提出原则性要求，确保规范性文件的前瞻性和科学性， 有效适应CIPS业务发展和功能升级的需要。 宏观经济 1、商务部新闻发言人7月4日表示，中美伦敦经贸会谈后，目前，中方正依法依规审批符合条件的管制 物项出口许可申请，美方也采取相应行动，取消对华采取的一系列限制性措施。 2、据国家能源局，近日，我国多地出现持续高温，带动用电负荷快速增长。7月4日，全国最大电力负 荷达到14.65亿千瓦，比6月底上升约2亿千瓦，比去年同期增长接近1.5亿千瓦，创历史新高。 3、民航局成立通用航空和低空经济工作领导小组。下一步，民航局将聚焦发展规划编制、航空器适航 审定、市场监管、飞行运营监管、飞行服务保障、飞行服务调度平台建设及安全监管体系建设等开展工 作，促进通用航空和低空经济安全有序发展。 4、国家税务总局增值税发票数据显示，今年前5个月，我国制造业企业销售收入同比增长4.2%。其 中，计算 ...

【导读】塞力医疗（603716）发布股票异常波动公告，参股公司降压疫苗新药临床试验获受理 7月4日晚，塞力医疗公告称，其持有华纪元生物15.61%股份，该公司的治疗性降压疫苗项目已完成概念验证阶段研究和临床前研究，并于2025年6月6日 获得国家药监局的新药临床试验申请受理。 2025年一季度末，摩根士丹利等四家QFII新进塞力医疗前十大流通股股东，持股总计约491.34万股。 近期，塞力医疗已连续4个交易日涨停。截至7月4日收盘，塞力医疗股价报21.08元/股，最新市值为40.3亿元。 华纪元生物降压疫苗 新药临床试验申请获受理 针对此次股票交易异常波动情况，塞力医疗7月4日晚公告称，经自查，目前公司生产经营活动一切正常，市场环境、行业政策没有发生重大调整，内部生 产经营秩序正常。控股股东及实际控制人不存在应披露而未披露的重大信息。 不过，塞力医疗表示，公司关注到近期市场对创新药业务关注度较高，公司持有武汉华纪元生物技术开发有限公司15.61%的股份，初始投资金额为1066.6 万元。 华纪元生物2024年实现营业收入2.68万元，净利润为-238.23万元。其治疗性降压疫苗项目HJY-ATRQβ-001已 ...

中国基金报记者 卢鸰 7 月 4 日晚， 塞力医疗 公告称，其持有华纪元生物 15.61% 股份，该公司的治疗性降压疫 苗项目已完成概念验证阶段研究和临床前研究，并于 2025 年 6 月 6 日获得国家药监局的新 药临床试验申请受理。 2025 年一季度末，摩根士丹利等四家 QFII 新进塞力医疗前十大流通股股东，持股总计约 491.34 万股。 近期，塞力医疗已连续 4 个交易日涨停。截至 7 月 4 日收盘，塞力医疗股价报 21.08 元 / 股，最新市值为 40.3 亿元。 华纪元生物 降压疫苗 新药临床试验申请获受理 【导读】塞力医疗发布股票异常波动公告，参股公司降压疫苗新药临床试验获受理 针对此次股票交易异常波动情况，塞力医疗 7 月 4 日晚公告称，经自查，目前公司生产经营 活动一切正常，市场环境、行业政策没有发生重大调整，内部生产经营秩序正常。控股股东 四家 QFII 一季度末总计持有 491 万股 财报显示， 塞力医疗 2024 年归母净利润为 -2.09 亿元，同比下降 31.95% ； 2025 年一 季度归母净利润为 -1432.09 万元，同比下降 553.66% 。 据塞力医疗 2 ...